Abstract
Objective
Adult-onset Still’s disease (AOSD) is an autoinflammatory disorder leading to multiorgan involvements. We sought to investigate mood status and the health-related quality of life (HRQoL) in these patients.
Methods
In this study, 82 AOSD patients and 82 age- and sex-matched healthy controls were included. Demographic and clinical data of recruited patients were collected. The Hospital Anxiety and Depression Scale (HADS) and Medical Outcomes Survey Short Form-36 (SF-36) were used to evaluate the mood status and quality of life, respectively. Spearman correlation and multivariable linear regression analyses were used to assess the disease-related risk factors associated with anxiety and depression.
Results
Forty-four active and thirty-eight relieved patients were enrolled. We found that scores of both HADS anxiety (HADS-A) and depression (HADS-D) subscales in active AOSD were significantly higher than inactive patients, which were significantly higher than controls. Moreover, the HADS-A was positively correlated to the patient’s global assessment (PGA), pain, and dosage of prednisone, and the HADS-D was positively correlated to systemic score, PGA, and pain. Female, high dosage of corticosteroids, and PGA more than 50 had a significant association with HADS-A score, while the sore throat and PGA more than 50 had a significant association with HADS-D score. Furthermore, AOSD patients’ anxiety and depression had a negative impact on HRQoL.
Conclusion
Active AOSD patients tended to be anxious and depressed, suffering from poorer HRQoL compared to patients in remission. Therefore, the evaluation of mental health and HRQoL should be included in AOSD patients’ long-term management.
Key Points • Adult-onset Still’s disease (AOSD) is a systemic inflammatory disorder leading to multiorgan involvement. This study was so far the first published research focuses on AOSD patients’ mental involvement and health-related quality of life (HRQoL). • Active AOSD patients were more tended to be anxious and depressive and suffered from poorer HRQoL compared to inactive patients. • Patients’ anxiety and depression were associated with impaired HRQoL. |
Similar content being viewed by others
References
Feist E, Mitrovic S, Fautrel B (2018) Mechanisms, biomarkers and targets for adult-onset Still’s disease. Nat Rev Rheumatol 14(10):603–618. https://doi.org/10.1038/s41584-018-0081-x
Ruscitti P, Cipriani P, Masedu F, Iacono D, Ciccia F, Liakouli V, Guggino G, Carubbi F, Berardicurti O, Di Benedetto P, Valenti M, Triolo G, Valentini G, Giacomelli R (2016) Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers. BMC Med 14(1):194. https://doi.org/10.1186/s12916-016-0738-8
Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Seve P (2014) Adult-onset Still’s disease. Autoimmun Rev 13(7):708–722. https://doi.org/10.1016/j.autrev.2014.01.058
Giacomelli R, Ruscitti P, Shoenfeld Y (2018) A comprehensive review on adult onset Still’s disease. J Autoimmun 93:24–36. https://doi.org/10.1016/j.jaut.2018.07.018
Ruscitti P, Giacomelli R (2018) Pathogenesis of adult onset Still’s disease: current understanding and new insights. Expert Rev Clin Immunol 14(11):965–976. https://doi.org/10.1080/1744666X.2018.1533403
Zeng T, Zou YQ, Wu MF, Yang CD (2009) Clinical features and prognosis of adult-onset Still’s disease: 61 cases from China. J Rheumatol 36(5):1026–1031. https://doi.org/10.3899/jrheum.080365
Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, Wierod A, Kalstad S, Rodevand E, Kroll F, Haugeberg G, Kvien TK (2017) Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis 76(11):1906–1910. https://doi.org/10.1136/annrheumdis-2017-211284
Kochar B, Barnes EL, Long MD, Cushing KC, Galanko J, Martin CF, Raffals LE, Sandler RS (2018) Depression is associated with more aggressive inflammatory bowel disease. Am J Gastroenterol 113(1):80–85. https://doi.org/10.1038/ajg.2017.423
Chi H, Liu D, Sun Y, Hu Q, Liu H, Cheng X, Ye J, Shi H, Yin Y, Liu M, Wu X, Zhou Z, Teng J, Yang C, Su Y (2018) Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity. Arthritis Res Ther 20(1):54. https://doi.org/10.1186/s13075-018-1555-6
Jia J, Shi H, Liu M, Liu T, Gu J, Wan L, Teng J, Liu H, Cheng X, Ye J, Su Y, Sun Y, Gong W, Yang C, Hu Q (2019) Cytomegalovirus infection may trigger adult-onset Still’s disease onset or relapses. Front Immunol 10:898. https://doi.org/10.3389/fimmu.2019.00898
Hu Q, Gong W, Gu J, Geng G, Li T, Tian R, Yang Z, Zhang H, Shao L, Liu T, Wan L, Jia J, Yang C, Shi Y, Shi H (2018) Plasma microRNA profiles as a potential biomarker in differentiating adult-onset Still’s disease from sepsis. Front Immunol 9:3099. https://doi.org/10.3389/fimmu.2018.03099
Hu QY, Zeng T, Sun CY, Luo CN, Liu S, Ding TT, Ji ZF, Lu A, Yimaiti K, Teng JL, Cheng XB, Ye JN, Su YT, Shi H, Sun Y, Chi HH, Zhou ZC, Chen LJ, Xu J, Jiang LD, Wu LJ, Lin J, Yang CD, Liu HL (2019) Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in China. Clin Exp Rheumatol 37 Suppl 121(6):52–57
Zou YQ, Lu LJ, Li SJ, Zeng T, Wang XD, Bao CD, Chen SL, Yang CD (2008) The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still’s disease. Clin Biochem 41(7–8):519–524. https://doi.org/10.1016/j.clinbiochem.2008.01.008
Sun Y, Wang Z, Chi H, Hu Q, Ye J, Liu H, Cheng X, Shi H, Zhou Z, Teng J, Yang C, Su Y (2019) Elevated serum levels of interleukin-10 in adult-onset Still’s disease are associated with disease activity. Clin Rheumatol 38:3205–3210. https://doi.org/10.1007/s10067-019-04642-x
Li Z, Liu HL, Chen J, Zeng T, He L, Li M, Luo C, Liu S, Ding TT, Yimaiti K, Teng J, Li X, Ding Y, Cheng X, Zhou J, Ye J, Ji J, Su YT, Shi H, Sun Y, Gao C, Hu Q, Chi H, Yuan X, Zhou Z, Wang D, Wang K, Li CG, Sun Y, Niu Y, Chen LJ, Xu J, Wu L, Zhou Z, Pan D, Niu H, Shi Y, Yang C (2020) Both HLA class I and II regions identified as genome-wide significant susceptibility loci for adult-onset Still’s disease in Chinese individuals. Ann Rheum Dis 79(1):161–163. https://doi.org/10.1136/annrheumdis-2019-215239
Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19(3):424–430
Li Q, Lin Y, Hu C, Xu Y, Zhou H, Yang L, Xu Y (2016) The Chinese version of hospital anxiety and depression scale: psychometric properties in Chinese cancer patients and their family caregivers. Eur J Oncol Nurs 25:16–23. https://doi.org/10.1016/j.ejon.2016.09.004
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD (1994) The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1):40–66. https://doi.org/10.1097/00005650-199401000-00004
Li L, Wang HM, Shen Y (2003) Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health 57(4):259–263. https://doi.org/10.1136/jech.57.4.259
Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M, Hill RO, Gutkowski A, Harth M, Myhal D et al (1991) Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70(2):118–136
Girard C, Rech J, Brown M, Allali D, Roux-Lombard P, Spertini F, Schiffrin EJ, Schett G, Manger B, Bas S, Del Val G, Gabay C (2016) Elevated serum levels of free interleukin-18 in adult-onset Still’s disease. Rheumatology (Oxford) 55(12):2237–2247. https://doi.org/10.1093/rheumatology/kew300
Schonau V, Schett G (2018) Response to: the value of 18(F)-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis 77(8):e53. https://doi.org/10.1136/annrheumdis-2017-212520
Nirmala N, Brachat A, Feist E, Blank N, Specker C, Witt M, Zernicke J, Martini A, Junge G (2015) Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity. Pediatr Rheumatol Online J 13:50. https://doi.org/10.1186/s12969-015-0047-3
Minoia F, Bovis F, Davi S, Horne A, Fischbach M, Frosch M, Huber A, Jelusic M, Sawhney S, McCurdy DK, Silva CA, Rigante D, Unsal E, Ruperto N, Martini A, Cron RQ, Ravelli A, Pediatric Rheumatology International Trials Organization tCA, Rheumatology Research Alliance tPRCSG, the Histiocyte S (2019) Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis 78(10):1357–1362. https://doi.org/10.1136/annrheumdis-2019-215211
Sampalis JS, Esdaile JM, Medsger TA Jr, Partridge AJ, Yeadon C, Senecal JL, Myhal D, Harth M, Gutkowski A, Carette S et al (1995) A controlled study of the long-term prognosis of adult Still’s disease. Am J Med 98(4):384–388. https://doi.org/10.1016/s0002-9343(99)80318-0
Soliday E, Grey S, Lande MB (1999) Behavioral effects of corticosteroids in steroid-sensitive nephrotic syndrome. Pediatrics 104(4):e51. https://doi.org/10.1542/peds.104.4.e51
Gonzalez-Perez O, Ramos-Remus C, Garcia-Estrada J, Luquin S (2001) Prednisone induces anxiety and glial cerebral changes in rats. J Rheumatol 28(11):2529–2534
Wohl Y, Mashiah J, Kutz A, Hadj-Rabia S, Cohen AD (2015) Pemphigus and depression comorbidity: a case control study. Eur J Dermatol 25(6):602–605. https://doi.org/10.1684/ejd.2015.2649
Hu Q, Shi H, Zeng T, Liu H, Su Y, Cheng X, Ye J, Yin Y, Liu M, Zheng H, Wu X, Chi H, Zhou Z, Jia J, Sun Y, Teng J, Yang C (2019) Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease. Arthritis Res Ther 21(1):9. https://doi.org/10.1186/s13075-018-1800-z
Nerurkar L, Siebert S, McInnes IB, Cavanagh J (2019) Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry 6(2):164–173. https://doi.org/10.1016/S2215-0366(18)30255-4
Tarakci E, Yeldan I, Kaya Mutlu E, Baydogan SN, Kasapcopur O (2011) The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol 30(11):1415–1420. https://doi.org/10.1007/s10067-011-1832-0
McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD (2014) Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 41(5):887–896. https://doi.org/10.3899/jrheum.130797
Postal M, Lapa AT, Sinicato NA, de Oliveira PK, Peres FA, Costallat LT, Fernandes PT, Marini R, Appenzeller S (2016) Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus. J Neuroinflammation 13:5. https://doi.org/10.1186/s12974-015-0471-9
Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcon GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V (2015) Mood disorders in systemic lupus erythematosus: results from an international inception cohort study. Arthritis Rheum 67(7):1837–1847. https://doi.org/10.1002/art.39111
Labrenz F, Ferri F, Wrede K, Forsting M, Schedlowski M, Engler H, Elsenbruch S, Benson S, Costantini M (2019) Altered temporal variance and functional connectivity of BOLD signal is associated with state anxiety during acute systemic inflammation. Neuroimage 184:916–924. https://doi.org/10.1016/j.neuroimage.2018.09.056
Zhang L, Zhang X, Zheng J, Liu Y, Wang J, Wang G, Zhang HP, Kang Y, Peng ZG, Ji YL, Wang L, Gibson PG, Wang G (2019) Depressive symptom-associated IL-1beta and TNF-alpha release correlates with impaired bronchodilator response and neutrophilic airway inflammation in asthma. Clin Exp Allergy 49(6):770–780. https://doi.org/10.1111/cea.13346
Hou R, Garner M, Holmes C, Osmond C, Teeling J, Lau L, Baldwin DS (2017) Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain Behav Immun 62:212–218. https://doi.org/10.1016/j.bbi.2017.01.021
Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D (2012) Interleukin-1beta causes anxiety by interacting with the endocannabinoid system. J Neurosci 32(40):13896–13905. https://doi.org/10.1523/JNEUROSCI.1515-12.2012
Swartz JR, Prather AA, Di Iorio CR, Bogdan R, Hariri AR (2017) A functional interleukin-18 haplotype predicts depression and anxiety through increased threat-related amygdala reactivity in women but not men. Neuropsychopharmacology 42(2):419–426. https://doi.org/10.1038/npp.2016.129
Schiltz JC, Sawchenko PE (2002) Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci 22(13):5606–5618
Pan W, Stone KP, Hsuchou H, Manda VK, Zhang Y, Kastin AJ (2011) Cytokine signaling modulates blood-brain barrier function. Curr Pharm Des 17(33):3729–3740. https://doi.org/10.2174/138161211798220918
Feldon M, Farhadi PN, Brunner HI, Itert L, Goldberg B, Faiq A, Wilkerson J, Rose KM, Rider LG, Miller FW, Giannini EH (2017) Predictors of reduced health-related quality of life in adult patients with idiopathic inflammatory myopathies. Arthritis Care Res 69(11):1743–1750. https://doi.org/10.1002/acr.23198
Yilmaz N, Can M, Oner FA, Kalfa M, Emmungil H, Karadag O, Yildiz F, Kimyon G, Yilmazer B, Gerdan V, Bilge SY, Ilhan B, Cobankara V, Kasifoglu T, Cefle A, Kisacik B, Onat AM, Akar S, Onen F, Erken E, Kiraz S, Aksu K, Keser G, Mumcu G, Direskeneli H (2013) Impaired quality of life, disability and mental health in Takayasu's arteritis. Rheumatology (Oxford) 52(10):1898–1904. https://doi.org/10.1093/rheumatology/ket238
Acknowledgments
Authors would like to thank the innovative research team of high-level local universities in Shanghai and all patients participated in this study.
Funding
This work was supported by the National Natural Science Foundation of China (81801600) and the Shanghai Sailing Program (18YF1414500).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
All patients provided written informed consent for participation in the survey and the use of data for publication. This survey was approved by the Institutional Research Ethics Committee of Ruijin Hospital (ID: 2016-61), Shanghai, China. All were conducted in accordance with the Helsinki declaration.
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 36 kb)
Rights and permissions
About this article
Cite this article
Chi, H., Jin, H., Wang, Z. et al. Anxiety and depression in adult-onset Still’s disease patients and associations with health-related quality of life. Clin Rheumatol 39, 3723–3732 (2020). https://doi.org/10.1007/s10067-020-05094-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-020-05094-4